Thus, preliminary analysis in a randomly selected subset of HNSCC patients and controls indicated that changes in mRNA expression of the BRCA2 and XPD genes in the tumour tissue of HNSCC patients were mirrored by the matched blood of the patients, such that expression of these two genes exhibited a trend of decrease with an increase in cancer stage. The gene discussed is ERCC2; the disease is neoplasm.